Skip to main content

Table 1 Vaccine release criteria was determined by pathogen load and phenotypic markers

From: Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4+IL17+ response

Assay

Test method

Result (median, range)

Specification

Viability (AO/Pl)

Fluorescence microscopy

87.0% (61.0%-94.0%)

>70%

HLA-DR

Flow cytometry

94.5% (69.5%-98.4%)

>70%

CD86

Flow cytometry

87.0% (61.5%-94.8%)

>70%

Endotoxin

LAL

<0.7 (<0.4-1.030)

<5 EU/mL

Gram stain

Standard

No organisms

No organisms

Sterility (14 days)

Bactec

No growth

No growth

Mycoplasma

PTC (28 day culture)

Negative

Negative